HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maciej Gasior Selected Research

sidnocarb (mesocarb)

5/2011Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maciej Gasior Research Topics

Disease

15Seizures (Absence Seizure)
01/2022 - 09/2002
7Epilepsy (Aura)
04/2014 - 09/2006
5Drug Resistant Epilepsy
01/2022 - 02/2008
5Schizophrenia (Dementia Praecox)
01/2012 - 08/2009
4Neurodegenerative Diseases (Neurodegenerative Disease)
06/2012 - 09/2006
3Alzheimer Disease (Alzheimer's Disease)
07/2016 - 09/2006
2Ketosis
07/2019 - 01/2015
2Glaucoma
01/2017 - 01/2012
2Pain (Aches)
10/2016 - 01/2016
2Disorders of Excessive Somnolence (Hypersomnia)
05/2011 - 11/2009
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2022
1CDKL5 deficiency disorder
01/2022
1Sleepiness
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1Fever (Fevers)
01/2022
1Autistic Disorder (Autism)
01/2018
1Eye Diseases (Eye Disease)
01/2017
1Chronic Pain
01/2016
1Mitochondrial Diseases (Mitochondrial Disease)
01/2012
1Bipolar Disorder (Manic Depressive Psychosis)
08/2009
1Body Weight (Weight, Body)
02/2008
1Partial Epilepsies (Epilepsy, Partial)
11/2007
1Traumatic Brain Injuries (Traumatic Brain Injury)
09/2006
1Parkinson Disease (Parkinson's Disease)
09/2006
1Brain Diseases (Brain Disorder)
09/2006
1Stroke (Strokes)
09/2006
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2005
1Alcohol Withdrawal Seizures
06/2004
1Mental Disorders (Mental Disorder)
08/2003

Drug/Important Bio-Agent (IBA)

9Anticonvulsants (Antiepileptic Drugs)IBA
07/2019 - 07/2003
4N-Methylaspartate (NMDA)IBA
01/2015 - 09/2002
4Pentylenetetrazole (Metrazol)IBA
04/2014 - 09/2002
4Cocaine (Cocaine HCl)IBA
07/2004 - 09/2002
3ganaxoloneIBA
01/2022 - 08/2003
3Kynurenic Acid (Kynurenate)IBA
07/2019 - 06/2012
3gamma-Aminobutyric Acid (GABA)IBA
07/2004 - 08/2003
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2010
2Abuse-Deterrent FormulationsIBA
10/2016 - 01/2016
2Opioid Analgesics (Opioids)IBA
10/2016 - 01/2016
2Antipsychotic Agents (Antipsychotics)IBA
01/2012 - 06/2011
2Dopamine (Intropin)FDA LinkGeneric
08/2010 - 11/2009
2AcetoneIBA
05/2009 - 04/2007
2BicucullineIBA
07/2003 - 09/2002
1BenzodiazepinesIBA
01/2022
1KynurenineIBA
07/2019
1Tryptophan (L-Tryptophan)FDA Link
07/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Retinaldehyde (Retinal)IBA
01/2017
1O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA
07/2016
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
07/2016
1Amyloid (Amyloid Fibrils)IBA
01/2016
1AcidsIBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1GluK2 Kainate ReceptorIBA
04/2014
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
04/2014
1PropionatesIBA
04/2014
1Kainic Acid (Kainate)IBA
04/2014
1Kainic Acid Receptors (Kainate Receptor)IBA
04/2014
1Botulinum Toxins (Botulinum Toxin)IBA
09/2013
16- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- oneIBA
01/2012
1sidnocarb (mesocarb)IBA
05/2011
1Glycine Plasma Membrane Transport ProteinsIBA
11/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2010
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2010
1P-30 composite resin (P 30)IBA
08/2010
1Wakefulness-Promoting AgentsIBA
11/2009
1Dopamine Agents (Dopaminergic Agents)IBA
11/2009
1LithiumIBA
08/2009
1ConvulsantsIBA
06/2009
1Phenytoin (Dilantin)FDA LinkGeneric
05/2009
1Lamotrigine (Lamictal)FDA LinkGeneric
05/2009
1KetonesIBA
05/2009
1Phenobarbital (Luminal)FDA Link
05/2009
1Carbamazepine (Tegretol)FDA LinkGeneric
05/2009
1Topiramate (Topamax)FDA LinkGeneric
05/2009
1Oxcarbazepine (Trileptal)FDA LinkGeneric
05/2009
1Valproic Acid (Depakote)FDA LinkGeneric
05/2009
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
11/2007
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2007
14-Aminopyridine (4 Aminopyridine)FDA Link
04/2007
14- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
10/2006
1Methylphenidate (Ritalin)FDA LinkGeneric
04/2005
1GABA-B ReceptorsIBA
07/2004
1vanoxerine (I 893)IBA
07/2004
1BaclofenFDA LinkGeneric
07/2004
1Aminophylline (Carine)FDA LinkGeneric
07/2004
1Adenosine (Adenocard)FDA LinkGeneric
07/2004
1GABA-B Receptor AgonistsIBA
07/2004
1phaclofenIBA
07/2004
1Methamphetamine (Desoxyn)FDA LinkGeneric
06/2004
1Chlormethiazole (Clomethiazole)IBA
06/2004
1GABA-A Receptors (GABA(A) Receptor)IBA
06/2004
1Pregnanolone (Allopregnanolone)IBA
08/2003
1NeurosteroidsIBA
08/2003

Therapy/Procedure

10Ketogenic Diet
07/2019 - 09/2006
1Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
01/2018
1Therapeutics
01/2012
1Intravenous Infusions
04/2007